OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 70 filers reported holding OCULAR THERAPEUTIX INC in Q4 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $132,000 | +41.9% | 33,279 | +42.9% | 0.01% | +33.3% |
| Q4 2018 | $93,000 | -41.5% | 23,286 | +0.7% | 0.01% | -14.3% |
| Q3 2018 | $159,000 | +32.5% | 23,122 | +29.7% | 0.01% | +40.0% |
| Q2 2018 | $120,000 | -45.9% | 17,822 | -50.5% | 0.01% | -54.5% |
| Q3 2017 | $222,000 | -22.6% | 36,021 | +16.3% | 0.01% | -26.7% |
| Q2 2017 | $287,000 | -40.8% | 30,962 | -40.8% | 0.02% | -31.8% |
| Q1 2017 | $485,000 | +8.7% | 52,300 | -2.1% | 0.02% | -18.5% |
| Q4 2016 | $446,000 | +134.7% | 53,400 | +38.9% | 0.03% | +200.0% |
| Q2 2016 | $190,000 | -78.8% | 38,433 | -59.9% | 0.01% | -79.1% |
| Q4 2015 | $898,000 | -36.6% | 95,877 | +42.3% | 0.04% | -8.5% |
| Q2 2015 | $1,417,000 | -42.9% | 67,399 | +14.1% | 0.05% | -45.3% |
| Q1 2015 | $2,480,000 | – | 59,092 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,932,607 | $40,643,000 | 15.56% |
| Lamond Capital Partners LLC | 711,533 | $14,964,000 | 15.19% |
| Polaris Venture Management Co. V, L.L.C. | 1,230,009 | $25,867,000 | 11.54% |
| NOTTINGHAM ADVISORS, INC. | 171,985 | $3,617,000 | 0.60% |
| Portolan Capital Management | 122,518 | $2,577,000 | 0.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 160,000 | $3,365,000 | 0.33% |
| Rotella Capital Management, Inc. | 18,461 | $388,000 | 0.32% |
| Monashee Investment Management LLC | 28,834 | $606,000 | 0.29% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 335,498 | $7,056,000 | 0.24% |
| BAILARD, INC. | 55,000 | $1,157,000 | 0.18% |